Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[ancestry category]	Characteristics[age]	Characteristics[developmental stage]	Characteristics[sex]	Characteristics[cell type]	Characteristics[disease]	Characteristics[sample amount]	Characteristics[biological replicate]	Characteristics[enrichment process]	Characteristics[enrichment method]	Material Type	Assay Name	Technology Type	Comment[technical replicate]	Comment[fraction identifier]	Comment[file uri]	Comment[instrument]	Comment[instrument]	Comment[MS2 analyzer type]	Comment[label]	Comment[cleavage agent details]	Comment[cleavage agent details]	Comment[modification parameters]	Comment[modification parameters]	Comment[modification parameters]	Comment[modification parameters]	Comment[dissociation method]	Comment[collision energy]	Comment[precursor mass tolerance]	Comment[fragment mass tolerance]	Comment[data file]
Sample 1	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	not available	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 1	proteomic profiling by mass spectrometry	1	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/F1_MM2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	F1_MM2.raw
Sample 1	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	not available	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 2	proteomic profiling by mass spectrometry	1	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/F2_MM2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	F2_MM2.raw
Sample 1	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	not available	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 3	proteomic profiling by mass spectrometry	1	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/F3_MM2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	F3_MM2.raw
Sample 1	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	not available	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 4	proteomic profiling by mass spectrometry	1	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/F4_MM2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	F4_MM2.raw
Sample 1	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	not available	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 5	proteomic profiling by mass spectrometry	1	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/F5_MM2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	F5_MM2.raw
Sample 1	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	not available	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 6	proteomic profiling by mass spectrometry	1	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/F6_MM2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	F6_MM2.raw
Sample 1	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	not available	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 7	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/FT_MM2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	FT_MM2.raw
Sample 2	Homo sapiens	human MM lymph node metastases tissues	not available	39	adult	male	not available	malignant melanoma	60 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 8	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM1_R1.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM1_R1.raw
Sample 3	Homo sapiens	human MM lymph node metastases tissues	not available	39	adult	male	not available	malignant melanoma	60 ug	2	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 9	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM1_R3.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM1_R3.raw
Sample 4	Homo sapiens	human MM lymph node metastases tissues	not available	51	adult	male	not available	malignant melanoma	60 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 10	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM2_R1.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM2_R1.raw
Sample 5	Homo sapiens	human MM lymph node metastases tissues	not available	51	adult	male	not available	malignant melanoma	60 ug	2	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 11	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM2_R2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM2_R2.raw
Sample 6	Homo sapiens	human MM lymph node metastases tissues	not available	71	adult	male	not available	malignant melanoma	60 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 12	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM3_R1.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM3_R1.raw
Sample 7	Homo sapiens	human MM lymph node metastases tissues	not available	71	adult	male	not available	malignant melanoma	60 ug	2	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 13	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM3_R2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM3_R2.raw
Sample 8	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	100 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 14	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_100ug_IMAC_Bravo_R1.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_100ug_IMAC_Bravo_R1.raw
Sample 8	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	100 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 15	proteomic profiling by mass spectrometry	2	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_100ug_IMAC_Bravo_R2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_100ug_IMAC_Bravo_R2.raw
Sample 8	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	100 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 16	proteomic profiling by mass spectrometry	3	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_100ug_IMAC_Bravo_R3.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_100ug_IMAC_Bravo_R3.raw
Sample 9	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	12 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 17	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_12ug_IMAC_Bravo_R1.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_12ug_IMAC_Bravo_R1.raw
Sample 9	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	12 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 18	proteomic profiling by mass spectrometry	2	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_12ug_IMAC_Bravo_R2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_12ug_IMAC_Bravo_R2.raw
Sample 9	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	12 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 19	proteomic profiling by mass spectrometry	3	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_12ug_IMAC_Bravo_R3.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_12ug_IMAC_Bravo_R3.raw
Sample 10	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	200 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 20	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_200ug_IMAC_Bravo_R1.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_200ug_IMAC_Bravo_R1.raw
Sample 10	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	200 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 21	proteomic profiling by mass spectrometry	2	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_200ug_IMAC_Bravo_R2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_200ug_IMAC_Bravo_R2.raw
Sample 10	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	200 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 22	proteomic profiling by mass spectrometry	3	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_200ug_IMAC_Bravo_R3.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_200ug_IMAC_Bravo_R3.raw
Sample 11	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	25 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 23	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_25ug_IMAC_Bravo_R1.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_25ug_IMAC_Bravo_R1.raw
Sample 11	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	25 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 24	proteomic profiling by mass spectrometry	2	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_25ug_IMAC_Bravo_R2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_25ug_IMAC_Bravo_R2.raw
Sample 11	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	25 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 25	proteomic profiling by mass spectrometry	3	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_25ug_IMAC_Bravo_R3.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_25ug_IMAC_Bravo_R3.raw
Sample 12	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	50 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 26	proteomic profiling by mass spectrometry	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_50ug_IMAC_Bravo_R1.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_50ug_IMAC_Bravo_R1.raw
Sample 12	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	50 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 27	proteomic profiling by mass spectrometry	2	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_50ug_IMAC_Bravo_R2.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_50ug_IMAC_Bravo_R2.raw
Sample 12	Homo sapiens	human MM lymph node metastases tissues	not available	not available	not available	not available	not available	malignant melanoma	50 ug	1	enrichment of phosphorylated Protein	Fe(III)-IMAC	tissue	run 28	proteomic profiling by mass spectrometry	3	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD011175/MM_50ug_IMAC_Bravo_R3.raw	NT=Q Exactive;AC=MS:1001911	NT=Q Exactive HF-X;AC=MS:1002877	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;TA=M;MT=variable;AC=UNIMOD:35	NT=Phospho;TA=S,T,Y;MT=variable;AC=UNIMOD:21	NT=Acetyl;PP=Protein N-term;MT=variable;AC=UNIMOD:1	NT=HCD;AC=MS:1000422	25% NCE	10 ppm	0.02 Da	MM_50ug_IMAC_Bravo_R3.raw
